<!DOCTYPE html>

<html>

<head>

<meta charset="utf-8" />
<meta name="generator" content="pandoc" />
<meta http-equiv="X-UA-Compatible" content="IE=EDGE" />

<meta name="viewport" content="width=device-width, initial-scale=1" />

<meta name="author" content="Johannes Cepicka, Lukas D. Sauer" />


<title>Introduction to planning phase II and phase III trials with drugdevelopR</title>

<script>// Pandoc 2.9 adds attributes on both header and div. We remove the former (to
// be compatible with the behavior of Pandoc < 2.8).
document.addEventListener('DOMContentLoaded', function(e) {
  var hs = document.querySelectorAll("div.section[class*='level'] > :first-child");
  var i, h, a;
  for (i = 0; i < hs.length; i++) {
    h = hs[i];
    if (!/^h[1-6]$/i.test(h.tagName)) continue;  // it should be a header h1-h6
    a = h.attributes;
    while (a.length > 0) h.removeAttribute(a[0].name);
  }
});
</script>

<style type="text/css">
code{white-space: pre-wrap;}
span.smallcaps{font-variant: small-caps;}
span.underline{text-decoration: underline;}
div.column{display: inline-block; vertical-align: top; width: 50%;}
div.hanging-indent{margin-left: 1.5em; text-indent: -1.5em;}
ul.task-list{list-style: none;}
</style>



<style type="text/css">
code {
white-space: pre;
}
.sourceCode {
overflow: visible;
}
</style>
<style type="text/css" data-origin="pandoc">
pre > code.sourceCode { white-space: pre; position: relative; }
pre > code.sourceCode > span { line-height: 1.25; }
pre > code.sourceCode > span:empty { height: 1.2em; }
.sourceCode { overflow: visible; }
code.sourceCode > span { color: inherit; text-decoration: inherit; }
div.sourceCode { margin: 1em 0; }
pre.sourceCode { margin: 0; }
@media screen {
div.sourceCode { overflow: auto; }
}
@media print {
pre > code.sourceCode { white-space: pre-wrap; }
pre > code.sourceCode > span { text-indent: -5em; padding-left: 5em; }
}
pre.numberSource code
{ counter-reset: source-line 0; }
pre.numberSource code > span
{ position: relative; left: -4em; counter-increment: source-line; }
pre.numberSource code > span > a:first-child::before
{ content: counter(source-line);
position: relative; left: -1em; text-align: right; vertical-align: baseline;
border: none; display: inline-block;
-webkit-touch-callout: none; -webkit-user-select: none;
-khtml-user-select: none; -moz-user-select: none;
-ms-user-select: none; user-select: none;
padding: 0 4px; width: 4em;
color: #aaaaaa;
}
pre.numberSource { margin-left: 3em; border-left: 1px solid #aaaaaa; padding-left: 4px; }
div.sourceCode
{ }
@media screen {
pre > code.sourceCode > span > a:first-child::before { text-decoration: underline; }
}
code span.al { color: #ff0000; font-weight: bold; } 
code span.an { color: #60a0b0; font-weight: bold; font-style: italic; } 
code span.at { color: #7d9029; } 
code span.bn { color: #40a070; } 
code span.bu { color: #008000; } 
code span.cf { color: #007020; font-weight: bold; } 
code span.ch { color: #4070a0; } 
code span.cn { color: #880000; } 
code span.co { color: #60a0b0; font-style: italic; } 
code span.cv { color: #60a0b0; font-weight: bold; font-style: italic; } 
code span.do { color: #ba2121; font-style: italic; } 
code span.dt { color: #902000; } 
code span.dv { color: #40a070; } 
code span.er { color: #ff0000; font-weight: bold; } 
code span.ex { } 
code span.fl { color: #40a070; } 
code span.fu { color: #06287e; } 
code span.im { color: #008000; font-weight: bold; } 
code span.in { color: #60a0b0; font-weight: bold; font-style: italic; } 
code span.kw { color: #007020; font-weight: bold; } 
code span.op { color: #666666; } 
code span.ot { color: #007020; } 
code span.pp { color: #bc7a00; } 
code span.sc { color: #4070a0; } 
code span.ss { color: #bb6688; } 
code span.st { color: #4070a0; } 
code span.va { color: #19177c; } 
code span.vs { color: #4070a0; } 
code span.wa { color: #60a0b0; font-weight: bold; font-style: italic; } 
</style>
<script>
// apply pandoc div.sourceCode style to pre.sourceCode instead
(function() {
  var sheets = document.styleSheets;
  for (var i = 0; i < sheets.length; i++) {
    if (sheets[i].ownerNode.dataset["origin"] !== "pandoc") continue;
    try { var rules = sheets[i].cssRules; } catch (e) { continue; }
    var j = 0;
    while (j < rules.length) {
      var rule = rules[j];
      // check if there is a div.sourceCode rule
      if (rule.type !== rule.STYLE_RULE || rule.selectorText !== "div.sourceCode") {
        j++;
        continue;
      }
      var style = rule.style.cssText;
      // check if color or background-color is set
      if (rule.style.color === '' && rule.style.backgroundColor === '') {
        j++;
        continue;
      }
      // replace div.sourceCode by a pre.sourceCode rule
      sheets[i].deleteRule(j);
      sheets[i].insertRule('pre.sourceCode{' + style + '}', j);
    }
  }
})();
</script>




<style type="text/css">body {
background-color: #fff;
margin: 1em auto;
max-width: 700px;
overflow: visible;
padding-left: 2em;
padding-right: 2em;
font-family: "Open Sans", "Helvetica Neue", Helvetica, Arial, sans-serif;
font-size: 14px;
line-height: 1.35;
}
#TOC {
clear: both;
margin: 0 0 10px 10px;
padding: 4px;
width: 400px;
border: 1px solid #CCCCCC;
border-radius: 5px;
background-color: #f6f6f6;
font-size: 13px;
line-height: 1.3;
}
#TOC .toctitle {
font-weight: bold;
font-size: 15px;
margin-left: 5px;
}
#TOC ul {
padding-left: 40px;
margin-left: -1.5em;
margin-top: 5px;
margin-bottom: 5px;
}
#TOC ul ul {
margin-left: -2em;
}
#TOC li {
line-height: 16px;
}
table {
margin: 1em auto;
border-width: 1px;
border-color: #DDDDDD;
border-style: outset;
border-collapse: collapse;
}
table th {
border-width: 2px;
padding: 5px;
border-style: inset;
}
table td {
border-width: 1px;
border-style: inset;
line-height: 18px;
padding: 5px 5px;
}
table, table th, table td {
border-left-style: none;
border-right-style: none;
}
table thead, table tr.even {
background-color: #f7f7f7;
}
p {
margin: 0.5em 0;
}
blockquote {
background-color: #f6f6f6;
padding: 0.25em 0.75em;
}
hr {
border-style: solid;
border: none;
border-top: 1px solid #777;
margin: 28px 0;
}
dl {
margin-left: 0;
}
dl dd {
margin-bottom: 13px;
margin-left: 13px;
}
dl dt {
font-weight: bold;
}
ul {
margin-top: 0;
}
ul li {
list-style: circle outside;
}
ul ul {
margin-bottom: 0;
}
pre, code {
background-color: #f7f7f7;
border-radius: 3px;
color: #333;
white-space: pre-wrap; 
}
pre {
border-radius: 3px;
margin: 5px 0px 10px 0px;
padding: 10px;
}
pre:not([class]) {
background-color: #f7f7f7;
}
code {
font-family: Consolas, Monaco, 'Courier New', monospace;
font-size: 85%;
}
p > code, li > code {
padding: 2px 0px;
}
div.figure {
text-align: center;
}
img {
background-color: #FFFFFF;
padding: 2px;
border: 1px solid #DDDDDD;
border-radius: 3px;
border: 1px solid #CCCCCC;
margin: 0 5px;
}
h1 {
margin-top: 0;
font-size: 35px;
line-height: 40px;
}
h2 {
border-bottom: 4px solid #f7f7f7;
padding-top: 10px;
padding-bottom: 2px;
font-size: 145%;
}
h3 {
border-bottom: 2px solid #f7f7f7;
padding-top: 10px;
font-size: 120%;
}
h4 {
border-bottom: 1px solid #f7f7f7;
margin-left: 8px;
font-size: 105%;
}
h5, h6 {
border-bottom: 1px solid #ccc;
font-size: 105%;
}
a {
color: #0033dd;
text-decoration: none;
}
a:hover {
color: #6666ff; }
a:visited {
color: #800080; }
a:visited:hover {
color: #BB00BB; }
a[href^="http:"] {
text-decoration: underline; }
a[href^="https:"] {
text-decoration: underline; }

code > span.kw { color: #555; font-weight: bold; } 
code > span.dt { color: #902000; } 
code > span.dv { color: #40a070; } 
code > span.bn { color: #d14; } 
code > span.fl { color: #d14; } 
code > span.ch { color: #d14; } 
code > span.st { color: #d14; } 
code > span.co { color: #888888; font-style: italic; } 
code > span.ot { color: #007020; } 
code > span.al { color: #ff0000; font-weight: bold; } 
code > span.fu { color: #900; font-weight: bold; } 
code > span.er { color: #a61717; background-color: #e3d2d2; } 
</style>




</head>

<body>




<h1 class="title toc-ignore">Introduction to planning phase II and phase
III trials with drugdevelopR</h1>
<h4 class="author">Johannes Cepicka, Lukas D. Sauer</h4>



<p>Suppose we are planning a drug development program testing the
superiority of an experimental treatment over a control treatment. Our
drug development program consists of an exploratory phase II trial which
is, in case of promising results, followed by a confirmatory phase III
trial.</p>
<p>The drugdevelopR package enables us to optimally plan such programs
using a utility-maximizing approach. Specifically, it calculates</p>
<ul>
<li>the optimal sample size for phase II and the resulting sample size
for phase III, as well as</li>
<li>the optimal go/no-go decision rule.</li>
</ul>
<p>The decision rule is the optimal threshold for deciding whether we
should proceed to phase III based on the results of phase II.
Optimization is performed with respect to a utility function which takes
the program’s cost, its success probability and its expected benefit
when successfully launching the new drug on the market into account.</p>
<p>But now, let’s get started with a hands-on example.</p>
<div id="the-example-setting" class="section level1">
<h1>The example setting</h1>
<p>Suppose we are developing a new tumor treatment, <em>exper</em>. The
patient variable that we want to investigate is the difference in tumor
width between the one-year visit and baseline. This is a normally
distributed outcome variable.</p>
<p>Within our drug development program, we will compare our experimental
treatment <em>exper</em> to the control treatment <em>contro</em>.
Building on available data, we expect that the mean tumor difference
amounts to <span class="math inline">\(20±1 \mathrm{mm}\)</span> for
<em>contro</em> and <span class="math inline">\(15±1
\mathrm{mm}\)</span> for <em>exper</em>. Furthermore, the variance is
assumed to be 8. The treatment effect is given as standardized
difference in mean (<span class="math inline">\(\Delta=\frac{\mu_{contro} -
\mu_{exper}}{\sigma}\)</span>). Thus, we obtain a standardized treatment
difference of <span class="math inline">\(\Delta_1 = 0.625\)</span>.</p>
</div>
<div id="applying-the-package-to-the-example" class="section level1">
<h1>Applying the package to the example</h1>
<p>After installing the package according to the <a href="https://sterniii3.github.io/drugdevelopR/#Installation">installation
instructions</a>, we can load it using the following code:</p>
<div class="sourceCode" id="cb1"><pre class="sourceCode r"><code class="sourceCode r"><span id="cb1-1"><a href="#cb1-1" tabindex="-1"></a><span class="fu">library</span>(drugdevelopR)</span></code></pre></div>
<div id="defining-all-necessary-parameters" class="section level2">
<h2>Defining all necessary parameters</h2>
<p>In order to apply the package to the setting from our example, we
need to specify the following parameters:</p>
<ul>
<li><code>Delta1</code> is the assumed true treatment effect, defined as
the standardized difference in means between the treatment arm and the
control arm. We will use the value <span class="math inline">\(\Delta_1
= 0.625\)</span> as defined above. For now, we will assume that the
treatment effects are fixed and independent of any prior distribution.
Thus, we will set <code>fixed = TRUE</code>.</li>
<li><code>n2min</code> and <code>n2max</code> specify the minimal and
maximal number of participants for the phase II trial. The package will
search for the optimal sample size within this region. For now, we want
the program to search for the optimal sample size in the interval
between 20 and 400 participants. In addition, we will tell the program
to search this region in steps of four participants at a time by setting
<code>stepn2 = 4</code>.</li>
<li><code>kappamin</code> and <code>kappamax</code> specify the minimal
and maximal threshold value for the go/no-go decision rule. The package
will search for the optimal threshold value within this region. For now,
we want the program to search in the interval between 0.02 and 0.2 while
going in steps of <code>stepkappa = 0.02</code>. Note that the lower
bound of the decision rule set for represents the smallest size of
treatment effect observed in phase II allowing to go to phase III, so it
can be used to model the minimally clinically relevant effect size.</li>
<li><code>c02</code> and <code>c03</code> are fixed costs for phase II
and phase III respectively. We will set the phase II costs to 15 and the
phase III costs to 20 (in <span class="math inline">\(10^5\)</span>$),
i.e. we have fixed costs of 1 500 000$ in phase II and 2 000 000$ in
phase III. Note that the currency of the input values does not matter,
so an input value for <code>c02</code> of 15 could also be interpreted
as fixed costs of 1 500 000€ if necessary.</li>
<li><code>c2</code> and <code>c3</code> are the costs in phase II and
phase III per patient. We will set them to be 0.675 in phase II and 0.72
in phase III. Again, these values are given in <span class="math inline">\(10^5\)</span>$, i.e. we have per patient costs of
67 500$ in phase II and 72 000$ in phase III.</li>
<li><code>b1</code>, <code>b2</code> and <code>b3</code> are the
expected small, medium and large benefit categories for successfully
launching the treatment on the market for each effect size category in
<span class="math inline">\(10^5\)</span>$. We will define a small
benefit of 3000, a medium benefit of 8000, and a large benefit of 10000.
The effect size categories directly correspond to the treatment effect,
i.e. if the treatment effect is between 0 and 0.5 (in standardized
differences of mean) we have a small treatment effect, hence yielding
expected benefits of the drug development program of 300 000 000$.</li>
<li><code>alpha</code> is the specified one-sided significance level. We
will set <code>alpha = 0.025</code>.</li>
<li>1 - <code>beta</code> is the minimal power that we require for our
drug development program. We will set <code>beta = 0.1</code>, meaning
that we require a power of 90%.</li>
<li>Further parameters: In more advanced settings, we would need to
pre-specify even more parameters. For now, we can set all remaining
parameters to <code>NULL</code>. Their use is explained in the <a href="https://sterniii3.github.io/drugdevelopR/articles/More_Parameters.html">vignette
on parameters</a> and in the <a href="https://sterniii3.github.io/drugdevelopR/articles/Fixed_and_prior_distributions.html">vigentte
on prior distributions</a>.</li>
</ul>
<p>Now that we have defined all parameters needed for our example, we
are ready to feed them to the package. We will use the function
<code>optimal_normal()</code>, which calculates the optimal sample size
and the optimal threshold value for a normally distributed outcome
variable.</p>
<div class="sourceCode" id="cb2"><pre class="sourceCode r"><code class="sourceCode r"><span id="cb2-1"><a href="#cb2-1" tabindex="-1"></a> res <span class="ot">&lt;-</span> <span class="fu">optimal_normal</span>(<span class="at">Delta1 =</span> <span class="fl">0.625</span>, <span class="at">fixed =</span> <span class="cn">TRUE</span>, <span class="co"># treatment effect</span></span>
<span id="cb2-2"><a href="#cb2-2" tabindex="-1"></a>                       <span class="at">n2min =</span> <span class="dv">20</span>, <span class="at">n2max =</span> <span class="dv">400</span>, <span class="co"># sample size region</span></span>
<span id="cb2-3"><a href="#cb2-3" tabindex="-1"></a>                       <span class="at">stepn2 =</span> <span class="dv">4</span>, <span class="co"># sample size step size</span></span>
<span id="cb2-4"><a href="#cb2-4" tabindex="-1"></a>                       <span class="at">kappamin =</span> <span class="fl">0.02</span>, <span class="at">kappamax =</span> <span class="fl">0.2</span>, <span class="co"># threshold region</span></span>
<span id="cb2-5"><a href="#cb2-5" tabindex="-1"></a>                       <span class="at">stepkappa =</span> <span class="fl">0.02</span>, <span class="co"># threshold step size</span></span>
<span id="cb2-6"><a href="#cb2-6" tabindex="-1"></a>                       <span class="at">c2 =</span> <span class="fl">0.675</span>, <span class="at">c3 =</span> <span class="fl">0.72</span>, <span class="co"># maximal total trial costs</span></span>
<span id="cb2-7"><a href="#cb2-7" tabindex="-1"></a>                       <span class="at">c02 =</span> <span class="dv">15</span>, <span class="at">c03 =</span> <span class="dv">20</span>, <span class="co"># maximal per-patient costs</span></span>
<span id="cb2-8"><a href="#cb2-8" tabindex="-1"></a>                       <span class="at">b1 =</span> <span class="dv">3000</span>, <span class="at">b2 =</span> <span class="dv">8000</span>, <span class="at">b3 =</span> <span class="dv">10000</span>, <span class="co"># gains for patients</span></span>
<span id="cb2-9"><a href="#cb2-9" tabindex="-1"></a>                       <span class="at">alpha =</span> <span class="fl">0.025</span>, <span class="co"># one-sided significance level</span></span>
<span id="cb2-10"><a href="#cb2-10" tabindex="-1"></a>                       <span class="at">beta =</span> <span class="fl">0.1</span>, <span class="co"># 1 - power</span></span>
<span id="cb2-11"><a href="#cb2-11" tabindex="-1"></a>                       <span class="at">Delta2 =</span> <span class="cn">NULL</span>, <span class="at">w =</span> <span class="cn">NULL</span>, <span class="at">in1 =</span> <span class="cn">NULL</span>, <span class="at">in2 =</span> <span class="cn">NULL</span>, </span>
<span id="cb2-12"><a href="#cb2-12" tabindex="-1"></a>                       <span class="at">a =</span> <span class="cn">NULL</span>,<span class="at">b =</span> <span class="cn">NULL</span>) <span class="co"># setting all unneeded parameters to NULL</span></span></code></pre></div>
</div>
<div id="interpreting-the-output" class="section level2">
<h2>Interpreting the output</h2>
<p>After setting all these input parameters and running the function,
let’s take a look at the output of the program.</p>
<div class="sourceCode" id="cb3"><pre class="sourceCode r"><code class="sourceCode r"><span id="cb3-1"><a href="#cb3-1" tabindex="-1"></a>res</span>
<span id="cb3-2"><a href="#cb3-2" tabindex="-1"></a><span class="co">#&gt; Optimization result:</span></span>
<span id="cb3-3"><a href="#cb3-3" tabindex="-1"></a><span class="co">#&gt;  Utility: 2946.07</span></span>
<span id="cb3-4"><a href="#cb3-4" tabindex="-1"></a><span class="co">#&gt;  Sample size:</span></span>
<span id="cb3-5"><a href="#cb3-5" tabindex="-1"></a><span class="co">#&gt;    phase II: 92, phase III: 192, total: 284</span></span>
<span id="cb3-6"><a href="#cb3-6" tabindex="-1"></a><span class="co">#&gt;  Probability to go to phase III: 1</span></span>
<span id="cb3-7"><a href="#cb3-7" tabindex="-1"></a><span class="co">#&gt;  Total cost:</span></span>
<span id="cb3-8"><a href="#cb3-8" tabindex="-1"></a><span class="co">#&gt;    phase II: 77, phase III: 158, cost constraint: Inf</span></span>
<span id="cb3-9"><a href="#cb3-9" tabindex="-1"></a><span class="co">#&gt;  Fixed cost:</span></span>
<span id="cb3-10"><a href="#cb3-10" tabindex="-1"></a><span class="co">#&gt;    phase II: 15, phase III: 20</span></span>
<span id="cb3-11"><a href="#cb3-11" tabindex="-1"></a><span class="co">#&gt;  Variable cost per patient:</span></span>
<span id="cb3-12"><a href="#cb3-12" tabindex="-1"></a><span class="co">#&gt;    phase II: 0.675, phase III: 0.72</span></span>
<span id="cb3-13"><a href="#cb3-13" tabindex="-1"></a><span class="co">#&gt;  Effect size categories (expected gains):</span></span>
<span id="cb3-14"><a href="#cb3-14" tabindex="-1"></a><span class="co">#&gt;   small: 0 (3000), medium: 0.5 (8000), large: 0.8 (10000)</span></span>
<span id="cb3-15"><a href="#cb3-15" tabindex="-1"></a><span class="co">#&gt;  Success probability: 0.85</span></span>
<span id="cb3-16"><a href="#cb3-16" tabindex="-1"></a><span class="co">#&gt;  Success probability by effect size:</span></span>
<span id="cb3-17"><a href="#cb3-17" tabindex="-1"></a><span class="co">#&gt;    small: 0.72, medium: 0.12, large: 0</span></span>
<span id="cb3-18"><a href="#cb3-18" tabindex="-1"></a><span class="co">#&gt;  Significance level: 0.025</span></span>
<span id="cb3-19"><a href="#cb3-19" tabindex="-1"></a><span class="co">#&gt;  Targeted power: 0.9</span></span>
<span id="cb3-20"><a href="#cb3-20" tabindex="-1"></a><span class="co">#&gt;  Decision rule threshold: 0.06 [Kappa] </span></span>
<span id="cb3-21"><a href="#cb3-21" tabindex="-1"></a><span class="co">#&gt;  Assumed true effect: 0.625 [Delta] </span></span>
<span id="cb3-22"><a href="#cb3-22" tabindex="-1"></a><span class="co">#&gt;  Treatment effect offset between phase II and III: 0 [gamma]</span></span></code></pre></div>
<p>The program returns a total of thirteen values and the input values.
For now, we will only look at the most important ones:</p>
<ul>
<li><code>res$n2</code> is the optimal sample size for phase II and
<code>res$n3</code> the resulting sample size for phase III. We see that
the optimal scenario requires 92 participants in phase II and 192
participants in phase III.</li>
<li><code>res$Kappa</code> is the optimal threshold value for the
go/no-go decision rule. We see that we need a treatment effect of more
than 0.06 in phase II in order to proceed to phase III.</li>
<li><code>res$u</code> is the expected utility of the program for the
optimal sample size and threshold value. In our case it amounts to
2946.07, i.e. we have an expected utility of 294 607 000$.</li>
</ul>
</div>
</div>
<div id="where-to-go-from-here" class="section level1">
<h1>Where to go from here</h1>
<p>This tutorial only covered drugdevelopR’s basic setting. Luckily, the
package’s functionality extends to a multitude of different settings. If
the example above doesn’t suit your needs, you can adapt it to your
specific setting:</p>
<ul>
<li><em>Different outcomes:</em> Apply it to <a href="https://sterniii3.github.io/drugdevelopR/articles/Binary_outcomes.html">binary
endpoints</a> and <a href="https://sterniii3.github.io/drugdevelopR/articles/Time-to-event_outcomes.html">time-to-event
endpoints</a>.</li>
<li><a href="https://sterniii3.github.io/drugdevelopR/articles/Interpreting_Output.html"><em>Interpreting
the rest of the output:</em></a> Obtain further details on your drug
development program.</li>
<li><a href="https://sterniii3.github.io/drugdevelopR/articles/Fixed_and_prior_distributions.html"><em>Fixed
or prior:</em></a> Model the assumed treatment effect on a prior
distribution.</li>
<li><a href="https://sterniii3.github.io/drugdevelopR/articles/More_Parameters.html"><em>More
parameters:</em></a> Define custom effect size categories. Put
constraints on the optimization by defining maximum costs, the total
expected sample size of the program or the minimum expected probability
of a successful program. Define an expected difference in treatment
effect between phase II and III. Skip phase II.</li>
<li><em>Complex drug development programs:</em> Adapt to situations with
<a href="https://sterniii3.github.io/drugdevelopR/articles/Bias_adjustment.html">biased
effect estimators</a>, <a href="https://sterniii3.github.io/drugdevelopR/articles/Multitrial.html">multiple
phase III trials</a>, <a href="https://sterniii3.github.io/drugdevelopR/articles/Multiarm_Trials.html">multi-arm
trials</a>, or <a href="https://sterniii3.github.io/drugdevelopR/articles/Multiple_Endpoints.html">multiple
endpoints</a>.</li>
<li><a href="https://sterniii3.github.io/drugdevelopR/articles/More_Parameters.html#parallel-computing"><em>Parallel
computing:</em></a> Be faster at calculating the optimum by using
parallel computing.</li>
</ul>
</div>



<!-- code folding -->


<!-- dynamically load mathjax for compatibility with self-contained -->
<script>
  (function () {
    var script = document.createElement("script");
    script.type = "text/javascript";
    script.src  = "https://mathjax.rstudio.com/latest/MathJax.js?config=TeX-AMS-MML_HTMLorMML";
    document.getElementsByTagName("head")[0].appendChild(script);
  })();
</script>

</body>
</html>
